FG-4592 in the Treatment of Anemia in Chronic Kidney Disease (CKD) Patients, Not on Dialysis, in Comparison to Darbepoetin Alfa
Condition: Anemia in Chronic Kidney Disease in Non-dialysis PatientsInterventions: Drug: FG-4592; Drug: darbepoetin alfaSponsors: Astellas Pharma Europe B.V.; FibroGenRecruiting - verified January 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials